HOME >> BIOLOGY >> NEWS
Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway

Using a functional genomic screen, scientists have defined elements that impact the responsiveness of cancer cells to drugs commonly used as anticancer therapeutics. The research, published in the June issue of the journal Cancer Cell, published by Cell Press, identifies individual genes that are associated with resistance to chemotherapeutic drugs and sets the stage for future studies that may significantly enhance the ability to predict whether or not a particular tumor will respond to treatment.

Resistance to chemotherapeutic drugs is the primary cause of treatment failure in patients with metastatic cancer. Dr. Julian Downward from the Cancer Research UK London Research Institute and colleagues used RNA interference to directly examine the contribution of over 800 candidate proteins to the sensitivity or resistance of cancer cells to several drugs that are commonly used to treat cancer.

Using this technique, the researchers found that resistance to the chemotherapeutic agent paclitaxel, a member of the taxane family, as expected, involves genes that impair drug-induced mitotic arrest following knockdown. Silencing of these genes in many cases also induces polyploidy and multinucleation in the absence of drug treatment. The researchers conclude that specific disruption of the mitotic checkpoint promotes paclitaxel resistance and that chromosomal numerical heterogeneity may be a useful predictor of paclitaxel resistance in some cancers.

Ceramide metabolism was identified as a critical regulator of sensitivity to a wide range of chemotherapeutic drugs. Although ceramide has been associated with apoptosis for some time, the mechanisms have not been well understood. In this study, decreased expression of a ceramide transport protein, COL4A3BP, sensitized cancer cells to multiple cytotoxic agents. Further, expression of COL4A3BP was increased in drug-resistant tumor cells and in a small cohort of ovarian cancers following paclitaxel
'"/>

Contact: Erin Doonan
edoonan@cell.com
617-397-2802
Cell Press
11-Jun-2007


Page: 1 2

Related biology news :

1. Dog DNA study yields clues to diverse size of breeds
2. Grizzly bears feast on diverse diet
3. Earths most diverse marine life found off Indonesias Papua Province
4. Ocean microbe census discovers diverse world of rare bacteria
5. Smithsonian guide to the biodiverse marine environment of Panamas Bocas del Toro
6. Sea urchins unexpectedly diverse innate immune capability points to new research avenue
7. Pathogens shape evolution of humans most diverse genes
8. Thumbnail sampler of 10 diverse physiology papers from IUPS 2005
9. A unique arrangement for egg cell division
10. Discovery in orange cauliflower may lead to more nutritious crops
11. When the villain becomes your friend: The strange tale of muscle lactate

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... October 01, 2019 , ... ... dispensing of chemicals, reagents, and medias and to be a more environmentally sustainable ... the culmination of years of experience and feedback from the original version we ...
(Date:9/30/2019)... ... September 30, 2019 , ... As human induced pluripotent stem cells (hiPSCs) ... the development and diseases of the human heart, there is an increasing need for ... muscle cells to be clearly and easily recorded. A study released today in STEM ...
(Date:9/25/2019)... (PRWEB) , ... September 25, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces its inaugural South ... Orleans BioInnovation Center in Louisiana. , Co-produced by Tulane University, this invitation-only ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... (PRWEB) , ... October 09, 2019 , ... ... 10th, groups of Montgomery County middle school and high school students have improved ... stressors, utilize relaxation techniques and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving ...
(Date:10/8/2019)... ... , ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces the ... precursor patent, approved in the U.S. in 2017, the new patent covers the company’s ... markets the technology in the U.S. as the AlphaSTEM Test™. The new patent ...
(Date:10/3/2019)... FAIRFAX, Va. (PRWEB) , ... October 02, 2019 , ... ... the prestigious NHS Digital Health Accelerator run by the East Midlands Academic Health Science ... up the adoption of technology in NHS by providing support to develop and deploy ...
(Date:9/24/2019)... Kong (PRWEB) , ... September 24, 2019 , ... Drug ... 2019 by the World Health Organization, with MRSA becoming one of the most serious ... there were 1,218 reported cases of community-associated MRSA (CA-MRSA), or a seven-fold of the ...
Breaking Biology Technology:
Cached News: